Institutional investors purchased a net $1.9 million shares of TROV during the quarter ended June 2017, and now own 20.54% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 2.1 Million shares of Trovagene Inc
SABBY CAPITAL LLC Bought 2.0 Million shares of Trovagene Inc